MIT CEO
June 14-15, 2027
Koch Institute at MIT
In order to further cultivate biomedical innovation and the advancement of medicines to help patients, Longwood Healthcare Leaders is gathering thought leaders across pharma, biotech, government, academia, healthcare, and investing for two days of discussion and networking. Join us for this not-to-be-missed event at MIT’s Koch Institute.
Longwood Healthcare Leaders MIT CEO is co-hosted with
Sally Kornbluth (President, MIT), Nobelist Phil Sharp (co-founder Biogen/Alnylam), Bob Langer (co-founder Moderna/Momenta), and Matthew Vander Heiden (Director, Koch Institute).
Co-Hosts
MIT CEO is co-hosted alongside leaders in the industry.
Bob Langer
Koch Institute Professor, MIT
Co-Founder, Moderna
Company 1
Christoph Westphal
General Partner, Longwood Fund
Founder/CEO, ALNY MNTA XLRN
Company 1
Matt Vander Heiden
Executive Director
Koch Institute at MIT
Company 1
Phil Sharp
Nobel laureate; Co-Founder, Alnylam/Biogen
Professor, MIT
Company 1
Sally Kornbluth
President
MIT
Company 1
Name 2
Title 2
Company 2
Name 2
Title 2
Company 2
Name 2
Title 2
Company 2
Name 2
Title 2
Company 2
2026 Featured Speakers
Leading BioPharma CEOs
Grace Colón
CEO
OmniPulse Biosciences
Company
Jeff Leiden
Executive Chair
Vertex
Company
Brett Monia
CEO
Ionis
Company
Marc Tessier-Lavigne
CEO
Xaira
Company
Chris Viehbacher
CEO
Biogen
Company
Renowned Academics & Leading Researchers
Atul Gawande
Former Assistant Administrator, Global Health
USAID (2022 – 2025)
Company
Bill Hait
Chief Scientific Advisor, AACR
former Global Head, Janssen R&D
Company
Anne Klibanski
CEO
Mass General Brigham
Company
Lotte Bjerre Knudsen
Lasker Award Winner
GLP1
Company
David Liu
Core Institute Member & Vice Chair of the Faculty
Broad Institute
Company
R&D Leaders
Uli Brödl
Head, R&D & CSO
Grünenthal
Company
Pushkal Garg
Chief R&D Officer
Alnylam
Company
Levi Garraway
CMO
Roche Genentech
Company
Fiona Marshall
President, Biomedical Research
Novartis
Company
George Yancopoulos
President & CSO
Regeneron
Company
Government, Regulatory & Policy Leaders
Maura Healey
Governor
Commonwealth of Massachusetts
Company
Peter Hutt
Former General Counsel
FDA
Company
Joe Kennedy III
Former Congressman
Massachusetts
Company
Seth Moulton
Congressman
Massachusetts
Company
Stephen Ubl
CEO
PhRMA
Company
Top BD & Strategy Executives
Andrew Baum
Senior Strategic Advisor
Pfizer
Company
Rachid Izzar
Head, Commercialization
Biogen
Company
Philippe Lopes-Fernandes
CBO
Ipsen
Company
Takashi Owa
Senior Corporate Group Officer, Head of External Innovation
Eisai
Company
Anne-Kathrin Witt
Enterprise Head, Strategy & Corporate Development
CSL
Company
Blue-Chip Investors
Jeanne Cunicelli
President
UPMC Enterprises
Company
Jason Fuller
Partner
Deerfield Management
Company
Raymond Kelleher
Managing Director
Cormorant
Company
Kush Parmar
Managing Partner
5AM Ventures
Company
Kiran Reddy
Senior Managing Director
Blackstone Life Science
Company
Highlights from last year's MIT CEO
Longwood Healthcare Leaders MIT CEO 2026
Longwood Healthcare Leaders MIT CEO 2026
Longwood Healthcare Leaders MIT CEO 2025
Longwood Healthcare Leaders MIT CEO 2024
Watch highlights from MIT CEO, including interviews with George Yancopoulos (President & CSO, Regeneron), Sally Kornbluth (President, MIT), Pushkal Garg (Chief R&D Officer, Alnylam), Fiona Marshall (President, BioMedical Research, Novartis), Lotte Bjerre Knudsen (Lasker Award Winner, GLP-1), Marc Tessier-Lavigne (CEO, Xaira), Brett Monia (CEO, Ionis Pharmaceuticals), among others.
Venue
Co-hosted with MIT leadership and held at MIT's Koch Institute in the heart of Cambridge, MA's Kendall Square, MIT CEO is located at 500 Main Street, Cambridge, MA.
Agenda
Monday, June 15, 2026
7:00 am | Registration & Networking Breakfast
7:40 am | Biotech Update & Longwood Fund Introduction
Christoph Westphal, General Partner, Longwood Fund
8:00 am | BioPharma Pipeline Sourcing
Uli Brödl, Head, R&D & CSO, Grünenthal
Jenny Laird, Global Head, BD, Neuroscience, Eli Lilly & Company
Michal Preminger, CEO, BioMed X Venture Labs
Morten Sogaard, SVP, Innovation Lab, Astellas
Moderator: Sekhar Naik, CEO, MResult
8:30 am | Driving Productivity in R&D
Sanjay Magavi, CSO, Progentos Therapeutics
Kenneth Moch, CEO, Regerna Therapeutics
Greg Tietjen, CEO, Revalia Bio
Dennis Velasquez, CCO, Biorce
Moderator: Amanda Wagner, CEO, Immunitas Therapeutics
9:00 am | Evolving Dealmaking Landscape
Polly Brown, Head, BD, Oncology R&D, AstraZeneca
Debbie Drane, Head, BD, Therapeutic Areas, CSL
Alan Ginsberg, Head, Global Licensing & BD, New TAs, EMD Serono
Andrew Wong, Head, Pharmaceutical Partnering, US, Chugai
Moderator: Bob Silverman, Head, Business Transactions, Formation Bio
9:30 am | Fireside Chat
Jeff Leiden, Executive Chair, Vertex
George Yancopoulos, President & CSO, Regeneron
Co-Moderators: Sekhar Naik, CEO, MResult
Christoph Westphal, General Partner, Longwood Fund
10:00 am | Networking Break
10:30 am | Aligning Priorities with the Board
Meeta Chatterjee, Former Chief Strategy Officer, Sun Pharma
Mahesh Karande, CEO, Stealth Bio
David Khougazian, Chairman, Montai
Paul Sekhri, CEO, vTv Therapeutics
Moderator: Jason Cole, CEO, Zag Bio
11:00 am | Maintaining Patient-Centric Focus
Jessica Grossman, CEO, IgGenix
Alessandro Maselli, CEO, Catalent
Jonathan Fleming, Chair, Cambridge Health Alliance Foundation
Vikram Sudarsan, CEO, Engrail Therapeutics
Moderator: Susan Abu-Absi, COO, Be Bio
11:30 am | Translating Science into Medicine
Vanessa Almendro Navarro, CCO, City of Hope
Don Ingber, Founding Director, Wyss Institute at Harvard
Brock Reeve, CEO, EOS Bioinnovation
Matthew Vander Heiden, Director, Koch Institute, MIT
Moderator: Seema Kumar, CEO, Cure.
12:00 pm | Networking Luncheon
1:00 pm | R&D Collaboration
Uli Bialucha, CSO, Xilio Therapeutics
Irene Blat, Head, External Innovation, Servier
Phil Chamberlain, CEO, Neomorph
Thomas Von Erlach, CEO, Vivtex
Moderator: Zhen Su, CEO, Marengo Therapeutics
1:30 pm | Developing High-Performing Teams
Nenad Grmusa, CEO, DEM Bio
Rachel Humphrey, CEO, Normunity
Bob Pozen, Senior Lecturer, MIT Sloan
Jim Weissman, Strategic Advisor, Jefferson Life Sciences
Moderator: Kara Carter, CEO, Viraccio Therapeutics
2:00 pm | Accelerating Drug Discovery
Sharon Benzeno, CCO, Adaptive Biotechnologies
Art Krieg, CEO, Zola Therapeutics
Michelle Longmire, CEO, Medable
Marc Tessier-Lavigne, CEO, Xaira
Brent Vaughan, CEO, Eratos Therapeutics
Moderator: John Lepore, CEO, ProFound Therapeutics
2:35 pm | Networking Break
3:00 pm | Pipeline Prioritization
Matthew Henn, President & CSO, Seres Therapeutics
Gavin MacBeath, CEO, TScan Therapeutics
Gilmore O'Neill, CEO, Editas Medicine
Moderator: Leslie Meltzer, Chief R&D Officer, Apellis Pharmaceuticals
3:30 pm | Positioning for Commercial Success
Geoff Chaiken, CEO, Blink Health
Peter Hutt, Former General Counsel, FDA
Rachid Izzar, Head, Commercialization, Biogen
Brett Monia, CEO, Ionis
Moderator: Helen Sabzevari, CEO, Precigen
4:00 pm | Fireside Chat
Bob Langer, Institute Professor, MIT; Co-Founder, Moderna/Momenta
Chris Viehbacher, CEO, Biogen
Moderator: Christoph Westphal, Founder/CEO, Momenta; General Partner, Longwood Fund
4:25 pm | Assessing Investment Risk
Anna French, Managing Partner, Qiming Venture Partners US
Omar Khalil, Managing Director, Sante Ventures
Kush Parmar, Managing Partner, 5AM Ventures
Geeta Vemuri, Managing Partner, Agent Capital
Moderator: Sean O’Connor, Principal, Longwood Fund
Tuesday, June 16, 2026
7:00 am | Registration & Networking Breakfast
7:40 am | Biotech Update & Longwood Fund Introduction
Vikas Goyal, Partner, Longwood Fund
8:00 am | Navigating the Regulatory Landscape
Andrew Baum, Senior Strategy Advisor, Pfizer
Ned Braunstein, EVP, Regulatory Affairs & Global Patient Safety, Regeneron
Lan Huang, CEO, BeyondSpring & SEED Therapeutics
Ed Kaye, CEO, Aurora Therapeutics
Moderator: Daniel Teper, Managing Partner, YADAY Health
8:30 am | Existing Pipelines: Maintaining Clinical Progress
Peter Joyce, CEO, Greywolf Therapeutics
Sabeen Mekan, CMO, Zymeworks
Jennifer Michaelson, CSO, Cullinan Therapeutics
Mani Mohindru, CEO, Cardiff Oncology
Moderator: Paul Peter Tak, CEO, Candel Therapeutics
9:00 am | Adapting to Funding Environment Constraints
Sandeep Gupta, CEO, Leukogene
Bill Lundberg, Former CEO, Merus
Peter Pfeiffer, CBO, GondolaBio
Jake Rubens, CEO, Serif
Moderator: Olga Granaturova, President, Prive Bio
9:30 am | Making RNAi into a New Class of Drugs: Alnylam Discoveries
Kevin Fitzgerald, CSO, Alnylam
Pushkal Garg, Chief R&D Officer, Alnylam
Moderator: Christoph Westphal, Founder/CEO, Alnylam
9:50 am | Networking Break
10:30 am | Fireside Chat
Levi Garraway, CMO, Roche Genentech
David Liu, Core Institute Member, Broad Institute
Moderator: Vikas Goyal, Partner, Longwood Fund
10:50 am | Ecosystem of External Innovation
Jeanne Cunicelli, President, UPMC Enterprises
Jeb Keiper, Venture Partner, Third Rock Ventures
Takashi Owa, Senior Corporate Group Officer & Head, External Innovation, Eisai
Anne-Kathrin Witt, Enterprise Head, Strategy & Corporate Development, CSL
Moderator: Philippe Lopes-Fernandes, CBO, Ipsen
11:20 am | Crossroads of Science & Policy: Sustaining the Engine of Innovation
Atul Gawande, Former Assistant Administrator, Global Health, USAID
Joe Kennedy III, Former Congressman, Massachusetts
Anne Klibanski, CEO, Mass General Brigham
Steve Ubl, CEO, PhRMA
Moderator: Susan Hockfield, President Emerita, MIT
11:50 am | Congressional Keynote
Seth Moulton, Congressman, Massachusetts
Moderator: Christoph Westphal, General Partner, Longwood Fund
12:05 pm | Networking Luncheon
1:00 pm | Advancing Late-Stage Assets
Anna Kazanchyan, CEO, Saghmos Therapeutics
Benjamine Liu, CEO, Formation Bio
Kia Motesharei, President & COO, ReAlta Life Sciences
Sarah Sheikh, Head, Neuroscience TA & Head, Global Development, Takeda
Moderator: Alison Holland, Chief Customer Officer, Medable
1:30 pm | Building Global Biopharmas
Mandana Honu, CBO, Fathom Therapeutics
Grace Kim, Chief Strategy Officer, Medincell
Jing Li, CEO, VelaVigo
Roger Pomerantz, Chair, Morphoceuticals
Moderator: Leif Pedersen, President, Certara
2:00 pm | Gubernatorial Keynote
Maura Healey, Governor, Massachusetts
Moderator: Christoph Westphal, General Partner, Longwood Fund
2:30 pm | Drug Approvals: Insights, Outlook, and Commitment to Patients
Lotte Bjerre Knudsen, Lasker Award Winner, GLP1
Bill Hait, Chief Scientific Advisor, AACR; Former Global Head, Janssen R&D
Vikram Karnani, CEO, Collegium Pharmaceutical
Sandeep Menon, Chief R&D Officer, BioCryst
Moderator: Raviv Pryluk, CEO, PhaseV
3:00 pm | The Evolving Needs of R&D
Carlos Bosques, CEO, Food Allergy Science Initiative
Grace Colón, CEO, OmniPulse Biosciences
Iain Kilty, CEO, Sitryx
Sammi Tang, SVP, Global Head, Quantitative Sciences & Evidence Generation, Astellas
Moderator: Marco Costa, COO, Causaly
3:30 pm | Networking Break
3:50 pm | Fireside Chat
Sally Kornbluth, President, MIT
Fiona Marshall, President, BioMedical Research, Novartis
Moderator: Christoph Westphal, General Partner, Longwood Fund
4:10 pm | Capital Formation and Strategic Partnerships
John Crowley, CFO, Centessa
Mary Fisher, CEO, Colorescience
Daniel Rosan, CFO & CBO, Ascidian Therapeutics
Derek Small, CEO, Syndeio Biosciences
Moderator: Kiran Reddy, Senior Managing Director, Blackstone Life Science
4:40 pm | Investment Outlook
Jonathan Behr, Partner, Dementia Discovery Fund, SV Health
Jason Fuller, Partner, Deerfield Management
Raymond Kelleher, Managing Director, Cormorant
Claudine Prowse, Venture Partner, JPM Private Capital
Moderator: Vikas Goyal, Partner, Longwood Fund
5:00 pm | Cocktail Reception
2026 Speaking Faculty
Susan Abu-Absi
COO
Be Bio
Company
Uli Bialucha
CSO
Xilio Therapeutics
Company
Polly Brown
Head, BD, Oncology R&D
AstraZeneca
Company
Pino Ciaramella
President
Beam Therapeutics
Company
Jeanne Cunicelli
President
UPMC Enterprises
Company
Anna French
Managing Partner
Qiming Venture Partners US
Company
Alan Ginsberg
Head, Global Licensing & BD, New TAs
EMD Serono
Company
Sandeep Gupta
CEO
Leukogene
Company
Alison Holland
Chief Customer Officer
Medable
Company
Don Ingber
Founding Director
Wyss Institute at Harvard
Company
Ed Kaye
CEO
Aurora Therapeutics
Company
Omar Khalil
Managing Director
Sante Ventures
Company
Lotte Bjerre Knudsen
Lasker Award Winner
GLP1
Company
Bob Langer
Koch Institute Professor, MIT
Co-Founder, Moderna
Company
David Liu
Core Institute Member & Vice Chair of the Faculty
Broad Institute
Company
Sanjay Magavi
CSO
Progentos Therapeutics
Company
Sandeep Menon
Chief R&D Officer
BioCryst
Company
Sean O’Connor
Principal
Longwood Fund
Company
Bob Pozen
Senior Fellow, Brookings Institution
Former President, Fidelity Investments
Company
Aleks Radovic-Moreno
Partner
Longwood Fund
Company
Rick Russell
CEO
Tract Bio
Company
Bob Silverman
VP, Business Transactions
Formation Bio
Company
Paul Peter Tak
CEO
Candel Therapeutics
Company
Stephen Ubl
CEO
PhRMA
Company
Chris Viehbacher
CEO
Biogen
Company
Anne-Kathrin Witt
Enterprise Head, Strategy & Corporate Development
CSL
Company
Irene Blat
Head, External Innovation
Servier
Company
Kara Carter
CEO
Viraccio Therapeutics
Company
Jason Cole
CEO
Zag Bio
Company
Debbie Drane
Head, BD, Therapeutic Areas
CSL
Company
Jason Fuller
Partner
Deerfield Management
Company
Vikas Goyal
Partner
Longwood Fund
Company
Bill Hait
Chief Scientific Advisor, AACR
former Global Head, Janssen R&D
Company
Mandana Honu
CBO
Fathom Therapeutics
Company
Rachid Izzar
Head, Commercialization
Biogen
Company
Anna Kazanchyan
CEO
Saghmos Therapeutics
Company
David Khougazian
Chairman
Montai
Company
Sally Kornbluth
President
MIT
Company
Jeff Leiden
Executive Chair
Vertex
Company
Michelle Longmire
CEO
Medable
Company
Fiona Marshall
President, Biomedical Research
Novartis
Company
Jennifer Michaelson
CSO
Cullinan Therapeutics
Company
Seth Moulton
Congressman
Massachusetts
Company
Kush Parmar
Managing Partner
5AM Ventures
Company
Raj Prasad
CFO
CRISPR Therapeutics
Company
Kiran Reddy
Senior Managing Director
Blackstone Life Science
Company
Helen Sabzevari
CEO
Precigen
Company
Derek Small
CEO
Syndeio Biosciences
Company
Sammi Tang
SVP, Global Head, Quantitative Sciences & Evidence Generation
Astellas
Company
Matt Vander Heiden
Executive Director
Koch Institute at MIT
Company
Thomas Von Erlach
CEO
Vivtex
Company
Andrew Wong
Head, Pharmaceutical Partnering, US
Chugai
Company
Andrew Baum
Senior Strategic Advisor
Pfizer
Company
Carlos Bosques
CEO
Food Allergy Science Initiative
Company
Geoffrey Chaiken
CEO
Blink Health
Company
Grace Colón
CEO
OmniPulse Biosciences
Company
Mary Fisher
CEO
Colorescience
Company
Pushkal Garg
Chief R&D Officer
Alnylam
Company
Olga Granaturova
President
Prive Bio
Company
Maura Healey
Governor
Commonwealth of Massachusetts
Company
Lan Huang
CEO
BeyondSpring & SEED Therapeutics
Company
Peter Joyce
CEO
Greywolf Therapeutics
Company
Jeb Keiper
Venture Partner
Third Rock Ventures
Company
Iain Kilty
CEO
Sitryx
Company
Art Krieg
CEO
Zola Therapeutics
Company
John Lepore
CEO
ProFound Therapeutics
Company
Philippe Lopes-Fernandes
CBO
Ipsen
Company
Alessandro Maselli
CEO
Catalent
Company
Kenneth Moch
CEO
Regerna Therapeutics
Company
Sekhar Naik
CEO
MResult
Company
Leif Pedersen
President
Certara
Company
Michal Preminger
CEO
BioMed X Venture Labs
Company
Brock Reeve
CEO
EOS Bioinnovation
Company
Paul Sekhri
CEO
vTv Therapeutics
Company
Morten Sogaard
SVP, Innovation Lab
Astellas
Company
Daniel Teper
Managing Partner
YADAY Health
Company
Brent Vaughan
CEO
Eratos Therapeutics
Company
Amanda Wagner
CEO
Immunitas
Company
George Yancopoulos
President & CSO
Regeneron
Company
Jonathan Behr
Partner, Dementia Discovery Fund
SV Health
Company
Ned Braunstein
EVP, Regulatory Affairs
Regeneron
Company
Phil Chamberlain
CEO
Neomorph
Company
Marco Costa
COO
Causaly
Company
Kevin Fitzgerald
CSO
Alnylam
Company
Levi Garraway
CMO
Roche Genentech
Company
Nenad Grmusa
CEO
DEM BioPharma
Company
Matthew Henn
President & CSO
Seres Therapeutics
Company
Rachel Humphrey
CEO
Normunity
Company
Mahesh Karande
CEO
Stealth Bio
Company
Raymond Kelleher
Managing Director
Cormorant
Company
Grace Kim
Chief Strategy Officer
Medincell
Company
Seema Kumar
CEO
Cure.
Company
Jing Li
CEO
VelaVigo
Company
Bill Lundberg
former CEO
Merus
Company
Sabeen Mekan
CMO
Zymeworks
Company
Mani Mohindru
CEO
Cardiff Oncology
Company
Gilmore O'Neill
CEO
Editas Medicine
Company
Peter Pfeiffer
CBO
GondolaBio
Company
Claudine Prowse
Venture Partner
JPM Private Capital
Company
Daniel Rosan
CFO & CBO
Ascidian Therapeutics
Company
Phil Sharp
Nobel laureate; Co-Founder, Alnylam/Biogen
Professor, MIT
Company
Zhen Su
CEO
Marengo Therapeutics
Company
Marc Tessier-Lavigne
CEO
Xaira
Company
Dennis Velasquez
CCO
Biorce
Company
Jim Weissman
Strategic Advisor
Jefferson Life Sciences
Company
Sharon Benzeno
CCO
Adaptive Biotechnologies
Company
Uli Brödl
Head, R&D & CSO
Grünenthal
Company
Meeta Chatterjee
former Chief Strategy Officer
Sun Pharma
Company
John Crowley
CFO
Centessa
Company
Jonathan Fleming
Chair
Cambridge Health Alliance Foundation
Company
Atul Gawande
Former Assistant Administrator, Global Health
USAID (2022 – 2025)
Company
Jessica Grossman
CEO
IgGenix
Company
Susan Hockfield
President Emerita
MIT
Company
Peter Hutt
Former General Counsel
FDA
Company
Vikram Karnani
CEO
Collegium Pharmaceutical
Company
Joe Kennedy III
Former Congressman
Massachusetts
Company
Anne Klibanski
CEO
Mass General Brigham
Company
Jenny Laird
Global Head, BD, Neuroscience
Eli Lilly & Company
Company
Benjamine Liu
CEO
Formation Bio
Company
Gavin MacBeath
CEO
TScan Therapeutics
Company
Leslie Meltzer
Chief R&D Officer
Apellis Pharmaceuticals
Company
Brett Monia
CEO
Ionis
Company
Takashi Owa
Senior Corporate Group Officer, Head of External Innovation
Eisai
Company
Roger Pomerantz
Chair
Morphoceuticals
Company
Raviv Pryluk
CEO
PhaseV
Company
Jacob Rubens
CEO
Serif
Company
Sarah Sheikh
Head, Global Development & SVP, Neuroscience
Takeda
Company
Vikram Sudarsan
CEO
Engrail Therapeutics
Company
Greg Tietjen
CEO
Revalia Bio
Company
Geeta Vemuri
Managing Partner
Agent Capital
Company
Christoph Westphal
General Partner, Longwood Fund
Founder/CEO, ALNY MNTA XLRN
Company
